Adarsha Koirala, Ph.D. - Publications
Affiliations: | 2012 | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Koirala A, Conley SM, Naash MI. Episomal maintenance of S/MAR-containing non-viral vectors for RPE-based diseases. Advances in Experimental Medicine and Biology. 801: 703-9. PMID 24664761 DOI: 10.1007/978-1-4614-3209-8_88 | 0.687 | |||
2013 | Koirala A, Conley SM, Makkia R, Liu Z, Cooper MJ, Sparrow JR, Naash MI. Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 745-52. PMID 24035979 DOI: 10.1016/J.Jconrel.2013.08.299 | 0.702 | |||
2013 | Koirala A, Conley SM, Naash MI. A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials. 34: 7158-67. PMID 23796578 DOI: 10.1016/J.Biomaterials.2013.06.002 | 0.672 | |||
2013 | Koirala A, Makkia RS, Conley SM, Cooper MJ, Naash MI. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA. Human Molecular Genetics. 22: 1632-42. PMID 23335596 DOI: 10.1093/Hmg/Ddt013 | 0.715 | |||
2012 | Han Z, Koirala A, Makkia R, Cooper MJ, Naash MI. Direct gene transfer with compacted DNA nanoparticles in retinal pigment epithelial cells: expression, repeat delivery and lack of toxicity. Nanomedicine (London, England). 7: 521-39. PMID 22356602 DOI: 10.2217/Nnm.11.158 | 0.688 | |||
2011 | Koirala A, Makkia RS, Cooper MJ, Naash MI. Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells. Biomaterials. 32: 9483-93. PMID 21885113 DOI: 10.1016/J.Biomaterials.2011.08.062 | 0.691 | |||
Show low-probability matches. |